Aug 17 (Reuters) - Altimmune Inc ::ALTIMMUNE FILES TO SAY OFFERING ABOUT 58 MILLION COMMON UNITS, EACH UNIT MADE OF 1 SHARE OF COMMON STOCK & A WARRANT TO PURCHASE 1 SHARE OF COMMON STOCK.
Full Article

March 28 (Reuters) - Altimmune Inc ::ALTIMMUNE ANNOUNCES FINANCIAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2017 AND PROVIDES CORPORATE UPDATE.ALTIMMUNE - AT DECEMBER 31, 2017, HAD CASH, CASH EQUIVALENTS, AND RESTRICTED CASH OF APPROXIMATELY $12.3 MILLION.
Full Article

Jan 3 (Reuters) - Altimmune Inc ::ALTIMMUNE ELECTS MITCHEL SAYARE, PH.D. AS CHAIRMAN OF ITS BOARD OF DIRECTORS.ALTIMMUNE INC - BOARD'S CURRENT CHAIRMAN, DAVID DRUTZ WILL REMAIN ON AS CHAIRMAN OF COMPENSATION COMMITTEE AND MEMBER OF BOARD.
Full Article

Aug 17 (Reuters) - Altimmune Inc :Altimmune announces $14.7 million Series B preferred stock offering.Altimmune - To use net proceeds from this financing for continued advancement of development activities for company's clinical-stage product pipeline​.
Full Article

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: